BMO Capital Initiates Coverage on MapLight Therapeutics, Inc. (MPLT) with Outperform

Market Context

MapLight Therapeutics, Inc. operates in the Healthcare sector. The stock currently trades at $37.44 with a market capitalization of $15.9M.

Analyst coverage from BMO Capital provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for MapLight Therapeutics, Inc..

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for MapLight Therapeutics, Inc.

Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Jul 21, 2026	UBS	Buy	N/A
Jul 21, 2026	BMO Capital	Outperform	N/A
Jul 10, 2026	Needham	Buy	N/A
Jun 25, 2026	Raymond James	Strong Buy	N/A
Jun 23, 2026	Craig-Hallum	Buy	N/A

Related Tools: Analyst Ratings Dashboard | View MPLT Stock Page